J Korean Soc Coloproctol.  2012 Oct;28(5):265-270. 10.3393/jksc.2012.28.5.265.

Initial Clinical Experience with Robotic Lateral Pelvic Lymph Node Dissection for Advanced Rectal Cancer

• Park JA
• Choi GS
• Park JS
• Park SY

• KMID: 2198691
• DOI: http://doi.org/10.3393/jksc.2012.28.5.265

Abstract

PURPOSE
This study was conducted to evaluate the technical feasibility and safety of robotic extended lateral pelvic lymph node dissection (LPLD) in patients with advanced low rectal cancer.
METHODS
A review of a prospectively-collected database at Kyungpook National University Medical Center from January 2011 to November revealed a series of 8 consecutive robotic LPLD cases with a preoperative diagnosis of lateral node metastasis. Data regarding patient demographics, operating time, perioperative blood loss, surgical morbidity, lateral lymph node status, and functional outcome were analyzed.
RESULTS
In all eight patients, the procedures were completed without conversion to open surgery. The mean operative time of extended pelvic node dissection was 38 minutes (range, 20 to 51 minutes), the mean number of lateral lymph nodes harvested was 4.1 (range, 1 to 13), and 3 patients (38%) were found to have lymph node metastases. Postoperative mortality and morbidity were 0% and 25%, respectively, but, there was no LPLD-related morbidity. The mean hospital stay was 7.5 days (range, 5 to 12 days).
CONCLUSION
Robotic LPLD is safe and feasible, with the advantage of being a minimally invasive approach. Further large-scale studies comparing robotic and conventional surgery with long-term follow-up evaluation are needed to confirm these findings.

Keyword

Robotic surgery; Pelvic lymph node dissection; Rectal cancer

MeSH Terms

Academic Medical Centers
Blood Loss, Surgical
Conversion to Open Surgery
Demography
Humans
Imidazoles
Length of Stay
Lymph Node Excision
Lymph Nodes
Neoplasm Metastasis
Nitro Compounds
Operative Time
Rectal Neoplasms
Imidazoles
Nitro Compounds